Responsiveness to Immune Checkpoint Inhibitors Is Associated With a Peripheral Blood T-Cell Signature in Metastatic Castration-Resistant Prostate Cancer

Donjete Simnica,Minke Smits,Edith Willscher,Lorenzo F. Fanchi,Iris S H Kloots,Inge M. van Oort,W.R. Gerritsen,Niven Mehra,Mascha Binder

Responsiveness to Immune Checkpoint Inhibitors Is Associated With a Peripheral Blood T-Cell Signature in Metastatic Castration-Resistant Prostate Cancer

2020

Donjete Simnica
Minke Smits
Edith Willscher
Lorenzo F. Fanchi
Iris S H Kloots
Inge M. van Oort
W.R. Gerritsen
Niven Mehra
Mascha Binder

PURPOSEAlthough most patients with microsatellite instable (MSI) metastatic castration-resistant prostate cancer (mCRPC) respond to immune checkpoint blockade (ICB), only a small subset of patients...

Keywords:

Cancer research
peripheral blood
castration resistant
Prostate cancer
Blockade
T cell
Medicine
immune checkpoint inhibitors
Immune checkpoint

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations